Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

TheraTech licenses pulmonary delivery devices

Jan. 22, 1997

Hybridon granted patent coverage for orally administered hybrid compounds

Jan. 21, 1997

Forbes files for U.S. patent related to membrane deficiencies

Jan. 20, 1997

IDEC licenses technology to Boehringer Ingelheim

Jan. 17, 1997

Medarex forms European subsidiary and research alliance

Jan. 17, 1997

Lilly and TheraTech drug collaboration

Jan. 16, 1997

ArQule and Signal expand drug discovery agreement

Jan. 16, 1997

NeXstar reveals new oligonucleotide synthesis method

Jan. 13, 1997

Labopharm granted US patent on drug delivery system

Jan. 10, 1997

Access/Strakan license agreement

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...